Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kezar Life to Participate in the TD Cowen 44th Annual Health Care Conference
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis